Led by a highly experienced team with in-depth expertise in AI and Biomedical Engineering.
Founder & CEO
MFE from UC Berkeley Haas School of Business, MS Artificial Intelligence (Georgia Tech), PhD Computational Biology (UAB) with structural biology postdoc. 16+ years in computational drug design across small molecule, protein, and RNA modalities. Senior Investigator at the Bill & Melinda Gates Foundation. Former Director & Senior Scientist at UAB Medicine. Founder & CEO of Ainnocence.
Senior Biologist
UC Davis (Biotechnology), pursuing dual masters in Molecular Biology and Bioinformatics. Former SRA/Scientist at Retro Biosciences (stem cell reprogramming, longevity research) and Sangamo Therapeutics (allogeneic cell therapies, Zinc Finger gene editing). Passionate about the convergence of biology, AI, and technology.
Scientific Advisor
Professor UCSF. Co-founder: Fate Therapeutics, Tenaya Therapeutics. Pioneer in chemical approaches to stem cell biology. 300+ publications.
Scientific Advisor
Wallace R. Bunn Endowed Chair, UAB. Former Director, UT Austin. Co-director Integrated Systems Center. Co-founder, Society for Design and Process Science. PhD Computer Science, Texas A&M.
Industry Advisor
20+ years preclinical drug discovery across oncology, immunology, neuroscience, and metabolic disease. Former Associate Principal Scientist at Merck & Co. (Schering-Plough) — advanced two compounds to clinical trials including the first-in-class ERK inhibitor MK-8353. Deep expertise in ADC/bsADC and degrader-antibody conjugate (DAC) design. PhD Organic Chemistry, UC Irvine.
We're always looking for exceptional talent to help us cure the incurables. Join our team of world-class scientists and engineers.
View Openings